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Anticancer activityAbstract Two series of novel bis(indole) analogues viz., N0-((5-substituted-1H-indol-3-
yl)methylene)-n-(1H-indol-3-yl)alkanehydrazides (7a–f) and N0-((5-substituted-1-(3-methylbut-2-e
nyl)-1H-indol-3-yl)methylene)-n-(1H-indol-3-yl)acetohydrazide (8a–f) were synthesized and charac-
terized by spectral analysis. The target molecules were screened for their antimicrobial, anticancer
activities and structure and activity relationship (SAR) was investigated. Compounds 7a, 7c and 8a
were found to be active in antimicrobial screening. Anticancer screening reveals that Compound 7c
was active against HeLa cell line with an IC50 of 43.1 lM and compound 7d was found to be
interesting candidate with an IC50 of 26.0 and 30.2 lM against Colo-205 and Hep G2 cell lines
respectively.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The indole skeleton is the interesting class of heterocyclic com-
pounds which has been stimulated by both their unique chem-
ical structure and the wide range of biological properties
(Barraja et al., 2011). In particular, C-3-substituted indoles
are important building blocks for the synthesis of many bio-
logically active compounds which possess antimalarial
(Agarwal et al., 2005), inhibitors of HIV-1 (Meanwell et al.,
2009), antimicrobial (Lakshmi et al., 2010; Reddy et al.,
2011), antioxidant (Lakshmi et al., 2010), anticancer
(Lakshmi et al., 2010), cytotoxic (Gu et al., 1999), inhibitorsicrobial
2 P. Choppara et al.of hepatitis C virus (Jin et al., 2014), anti-diabetic (Rajesh
et al., 2007), and neuro protective (Mohareb et al., 2011) activ-
ities. On the other hand, N-1 and C-3-substituted indole
derivatives have been found to play an important role in many
biologically active compounds especially with anti-
inﬂammatory (Hall et al., 2008; Singh et al., 2008), anticancer
(Singh et al., 2008; Madadi et al., 2014), anti-nociceptive
(Adam et al., 2010) and antipsychotic (Madadi et al., 2013)
activities. Marine indole alkaloids have emerged as an impor-
tant structural class exhibiting antiviral, antimicrobial and
antitumor activity (Dembitsky et al., 2005; Bao et al., 2005;
Oh et al., 2005, 2006). Among these biologically active scaf-
folds, bis(indole) alkaloids with a broad spectrum of biological
activities are being discovered from marine invertebrates such
as sponges, bryozoans, coelenterates and tunicates (Yang and
Cordell, 1997; Tsuda et al., 2005; Shin et al., 1999; Ryan and
Drennan, 2009; Diana et al., 2010). Dragmacidin D and top-
sentins and their analogues exhibited activities in vitro and
in vivo against P388 murine and human tumor cells (Wright
et al., 1992; Tsujii and Rinehart, 1988). Coscinamides A–C
were isolated from Coscinoderma sps a marine sponge and
exhibit cycloprotection against HIV in the NCI assay
(Bokesch et al., 2000; Bacher et al., 2001). Asterriquinone B1
was isolated from Aspergillus terreus which is a bis(indole)
derivative with 2,5-dimethoxy benzoquinone as a spacer and
is effective in inhibiting the growth of several transplantable
animal tumors in vivo (Liu et al., 1999). Nortopsentins A–C
were isolated from a marine sponge Spongosorites ruetzleri
having a 2,4-bis(3-indolyl)imidazole skeleton and exhibited
in vitro cytotoxicity against P388 cell line (Alvarez and Salas,
1991; Sakem and Sun, 1991; Kawasaki et al., 1996). The struc-
tures of the naturally occurring bis(indole) molecules are pre-
sented in Fig. 1.
A great limitation in the use of the reservoir of marine
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material. Due to the interesting biological activities, different
analogues of the marine nortopsentins have been synthesized
in which the imidazole moiety of the nortopsentin was replaced
by ﬁve- or six-membered heterocyclic rings such as thiazole
(Parrino et al., 2015; Carbone et al., 2015, 2013; Carbone
et al., 2014), pyrazinone (Jiang and Gu, 2000), pyrimidines,
pyrazines (Jiang et al., 2001), thiophenes (Diana et al.,
2007a), pyridines (Xiong et al., 2001), pyrazoles (Diana
et al., 2007b) and 1,2,4-thiadiazoles (Kumar et al., 2011) which
were reported for their cytotoxicity against several cancer cell
lines.
The acylhydrazones [(hydrazide–hydrazone (ACOANHA
N‚CHA)] are classiﬁed as important functional group which
exhibit signiﬁcant role in anti-inﬂammatory (Todeschini et al.,
1998; Radhwan et al., 2007; Gaston et al., 1996; Almasirad
et al., 2005; Murineddu et al., 2001), antimalarial (Gemma
et al., 2006), antimicrobial (Masunari and Tavares, 2007;
Kuc¸ukguzel et al., 2002), anticonvulsant (Dimmock et al.,
2000; Ragavendran et al., 2007), antitumor (Bernhardt et al.,
2009; Whitnall et al., 2006; Vicini et al., 2006; Terzioglu and
Gursoy, 2003; Abadi et al., 2003), analgesic (Lima et al.,
2000), antiplatelet (Silva et al., 2004) and antitubercular
(Vavrikova et al., 2011a; Manvar et al., 2008; Vavrikova
et al., 2011b) activities. In recent years, researchers have turned
their interest by replacing the central heterocyclic spacer of the
bis(indole) alkaloids with biologically active long chain linkers
such as glyoxylamide derivatives (Gupta et al., 2007), and
acylhydrazones and their cytotoxic activity was evaluated
against human cancer cell lines (Kumar et al., 2012).
Keeping the literature survey in view, we plan to synthesize
the novel bis(indole) analogues by replacing the central spacer
(heterocyclic and long chain) with alkane hydrazone spacer.
All the synthesized compounds were screened for antimicrobial
and anticancer activities.N
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Synthesis, characterization and cytotoxic investigation of bis(indole) analogues 32. Results and discussion
2.1. Chemistry
Synthesis of two series of novel bis(indole) analogues viz.,
N0-((5-substituted-1H-indol-3-yl)methylene)-n-(1H-indol-3-yl)
alkanehydrazides (7a–f) and N0-((5-substituted-1-(3-methyl
but-2-enyl)-1H-indol-3-yl)methylene)-n-(1H-indol-3-yl)aceto-
hydrazide (8a–f) has been accomplished by adopting known
synthetic routes. Indole-3-carboxylic acids namely, indole-3-
acetic (1a), indole-3-propionic (1b) and indole-3-butyric acid
(1c) were selected as precursors, which on reﬂux with 4 N
HCl in the presence of MeOH for 2–3 h to yield Indole-3-
carboxylic methyl esters (2a–c), and these methyl esters on
reaction with hydrazine hydrate in the presence of MeOH
under reﬂuxing conditions for 2–3 h yield three different acyl-
hydrazides chain linkers (3a–c) (Scheme 1).
Indoles (4) were formylated by Vilsmeier-Haack reaction to
yield 3-Formyl Indoles (5), that were prenylated by the reac-
tion with Prenyl bromide in the presence of NaH, DMF at
0 C for 15 min to yield N-prenylated 3-formyl indoles (6)
(Scheme 2).
The series of N0-((5-substituted-1H-indol-3-yl)methylene)-
n-(1H-indol-3-yl)alkanehydrazides (7a–f) were achieved by
the condensation of indole-3-substituted acylhydrazides (3a–
c) with 5-substituted-1H-indole-3-carbaldehyde (5a,b) in the
presence of EtOH and catalytic amount of Glac. acetic acid
under reﬂuxing conditions for 20–45 min. Similarly the con-
densation of indole-3-substituted acylhydrazides (3a–c) with
5-substituted-1-(3-methylbut-2-enyl)-1H-indole-3-
carbaldehyde (6a,b) in the presence of EtOH and 1–2 drops of
Glac. acetic acid under reﬂuxing conditions for 20–45 min
yields novel N0-((5-substituted-1-(3-methylbut-2-enyl)-1H-
indol-3-yl)methylene)-n-(1H-indol-3-yl)acetohydrazide (8a–f)
(Scheme 3).N
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advanced spectroscopic techniques (1H, 13C, Mass, IR and ele-
mental analysis).
2.2. Bio evaluation
2.2.1. Antimicrobial activity
The newly synthesized and well characterized compounds (7a–
f) and (8a–f) were screened for in vitro antibacterial activity
against Gram positive bacterium (Bacillus subtilis), Gram neg-
ative bacteria (Escherichia coli, Klebsiella pneumonia,
Pseudomonas aeruginosa) and antifungal activity against
Aspergillus ﬂavus, Aspergillus niger, Candida albicans using
agar well diffusion assay and zones of inhibition of the test
compounds were expressed in mm.
2.2.1.1. Antibacterial activity. The antibacterial activity of the
test compounds (7a–f) and (8a–f) was compared with standard
‘‘ciproﬂoxacin’’ and the results are presented in Table 1.
As indicated in Table 1, most of the synthesized compounds
generally showed potent antibacterial activity against all the
tested bacterial strains. Compound 7a shows good antibacte-
rial activity against B. subtilis, K. pneumonia and P. aeruginosa
with zones of inhibition of 22, 21 and 24 mm respectively. In
case of E. coli, compound 7c is more active with a zone of
inhibition of 21 mm. On bacterial strains, compound 7a is
potent against P. auregenosa with a zone of 24 mm.
Considering the activity of compounds 8, with the exception
of compound 8e, showed a decreased bactericidal activity
suggesting that the presence of the hydrophobic prenyl group
does not improve the biological activity.
2.2.1.2. Antifungal activity. The antifungal activity of tested
compounds (7a–f) and (8a–f) was compared with ketoconazole
(standard) and the results are tabulated in Table 2.n
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Scheme 3 Synthesis of N0-((5-substituted-1H-indol-3-yl)methylene)-n-(1H-indol-3-yl)alkanehydrazides (7a–f) and N0-((5-substituted-1-
(3-methylbut-2-enyl)-1H-indol-3-yl)methylene)-n-(1H-indol-3-yl)acetohydrazide (8a–f).
Table 1 Zones of inhibition (mm)a of compounds 7a–f and
8a–f against tested bacterial strains.
Entry Compound Bacterial strains
B.
subtilis
E. coli K.
pneumonia
P.
auregenosa
1 7a 22 19 21 24
2 7b 19 20 19 16
3 7c 18 21 20 20
4 7d 20 20 18 20
5 7e 19 14 15 23
6 7f 21 14 19 16
7 8a 18 16 20 19
8 8b 18 16 19 21
9 8c 16 14 14 18
10 8d 19 20 19 18
11 8e 20 17 20 20
12 8f 20 14 20 16
13 Standarda 24 27 22 26
Ciproﬂoxacin was used as standard.
a 100 lg/mL of compound in each well.
Table 2 Zones of inhibition (mm)a of compounds 7a–f and
8a–f against tested fungal strains.
Entry Compound A. ﬂavus A. niger C. albicans
1 7a 16 18 14
2 7b 13 14 12
3 7c 12 16 13
4 7d 12 14 13
5 7e 15 12 14
6 7f 15 16 15
7 8a 14 13 16
8 8b 10 12 15
9 8c 12 10 9
10 8d 10 11 14
11 8e 9 10 12
12 8f 10 12 9
13 Standarda 21 23 19
Ketoconazole was used as standard.
a 100 lg/mL of compound in each well.
4 P. Choppara et al.The results tabulated in Table 2 infer that compound 7a
was found to be interesting molecule with good antifungal
activity against A. ﬂavus and A. niger with zone of inhibition
of 16 and 18 mm respectively. Compound 8a is potent against
C. albicans with a zone of 16 mm. Compounds 7a and 8a are
acetohydrazide analogues, in which compound (7a) belongs
to unprenylated series, whereas compound 8a comes under
prenylated series.
2.2.2. In vitro anti cancer activity
The anti-proliferative/cytotoxic activities of the newly synthe-
sized bis(indole) analogues (7a–f) and (8a–f) were evaluatedPlease cite this article in press as: Choppara, P. et al., Synthesis, characterization a
study. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015against three different types of human cancer cell lines, viz.,
human colorectal cancer (Colo-205), human hepatocellular
liver carcinoma (Hep G2), and human cervical cancer (HeLa)
using the MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl
tetrazolium bromide] assay, according to the method of
Mossman (Mosmann, 1983). The cytotoxic potency of the
compounds varied between the cell lines suggesting a structural
property of these compounds as possible determinants of their
biological activity. The cytotoxic investigations were evaluated
at IICT, Hyderabad, in association with Dr. J.V. Rao,
Scientist, Biology division.
It is evident from the results that all the target compounds
have shown signiﬁcant cytotoxic activity against all the tested
cell lines (Table 3). However, 8e and 8f are found to be inactivend cytotoxic investigations of novel bis(indole) analogues besides antimicrobial
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tion. Etoposide (a standard drug molecule) was used as a pos-
itive control in these assays and the IC50 values were recorded
for Colo-205, Hep G2, and HeLa as 0.45, 4.75 and 23.3 lM
respectively. Among the derivatives, about 45–55% of the test
compounds have shown effective inhibition of growth in all the
cell lines at less than 100 lM concentration.
Compound 7c exhibited an excellent anti-proliferative
activity against all the cell lines (IC50 values are less than
50 lM conc.) followed by 7d, 8a, 7e and 7f. Furthermore,
results indicated based on the IC50 values, the Hep G2 cell lines
appear to be more sensitive than Colo-205 and HeLa cell lines.
Nevertheless, the order of relative sensitivity among the cell
lines differs, when compared to the activity of etoposide. All
the bis(indole) analogues (7a–f) and (8a–f) were found to be
effective anti-proliferative agents against HeLa cells, with 2
to 10-fold less active than the IC50 value of etoposide.
Similarly, the analogues 7c, 7d, 7e, 7f and 8a, have exhibited
potent anti-proliferative activity against Hep G2 cell lines.
Likewise, these analogues (excluding 7f) also showed moderate
cytotoxicity against Colo-205 cell lines.
2.2.3. Structure Activity Relationship (SAR)
The compounds, 5-bromo substituted aceto and propanehy-
drazides (7d and 7e) were found to be active against all the
three cell lines than the corresponding unsubstituted aceto
and propanehydrazides (7a and 7b) which indicates that
hydrophobic bromine increases the activity. But there is an
exception from the above hypothesis that the presence of bro-
mine on position 5 in butanehydrazide (7f) slightly decreases
the cytotoxicity than its corresponding unsubstituted butane-
hydrazide (7c).
Introduction of prenyl group increases the activity of 8a
against Colo-205, 8a and 8b against Hep-G2 and 8a, 8b andTable 3 In vitro cytotoxicity of bis (indole) derivatives (7a–f)
and (8a–f) against Colo-205, Hep G2 and HeLa human cancer
cells by MTT assay expressed in IC50 (lM).
Entry Compound aIC50 (lM)
Colo-205 Hep G2 HeLa
1 7a 58.1 247 232
2 7b 136 274 248
3 7c 35.6 34.7 43.1
4 7d 26.0 30.2 61.4
5 7e 34.9 37.5 101
6 7f 88.7 68.1 65.2
7 8a 42.1 34.3 64.3
8 8b 216 153 229
9 8c 177 103 157
10 8d 142 154 121
11 8e NA NA 187
12 8f NA NA 62.7
13 StandardA 0.45 4.75 23.3
NA indicates that the compound is inactive at 300 lM.
a IC50 is deﬁned as the concentration, which results in a 50%
decrease in cell number as compared with that of the control cul-
tures in the absence of an inhibitor and was calculated using the
respective regression analysis. The values represent the mean of
three individual observations.
A Etoposide was used as positive control.
Please cite this article in press as: Choppara, P. et al., Synthesis, characterization an
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aceto and propanehydrazides (8a and 8b) exhibited potent
cytotoxicity than their corresponding 5-bromo substituted
aceto and propanehydrazides (8d and 8e) which indicates that
hydrophobic bromine decreases the activity. In contrast, bro-
mine on 5th position in butanehydrazide (8f) increases the
cytotoxicity than its corresponding 5-bromo substituted aceto
and propanehydrazides (8d and 8e). The relative cytotoxicity
of prenylated series (8a–f) against the three cell lines is in the
order of HeLa > Hep-G2 > Colo-205.
In unprenylated series (7a–f), 5-bromo substituted aceto
and propanehydrazides (7d and 7e) and unsubstituted butane-
hydrazide (7c) exhibited potent cytotoxicity. In contrast the
prenyl moiety alters the activity that unsubstituted aceto and
propanehydrazides (8d and 8e) and 5-bromo substituted
butanehydrazide (8f) were the interesting candidates in preny-
lated series (8a–f).
3. Conclusion
Among the novel series N0-((5-substituted-1H-indol-3-
yl)methylene)-n-(1H-indol-3-yl)alkanehydrazides (7a–f) and
N0-((5-substituted-1-(3-methylbut-2-enyl)-1H-indol-3-yl)meth-
ylene)-n-(1H-indol-3-yl)acetohydrazide (8a–f) compounds 7a
(B. subtilis, K. pneumonia and P. aeruginosa) and 7c (E. coli)
are potent for antibacterial activity and compounds 7a
(Aspergillus sps) and 8a (C. albicans) exhibit good antifungal
activity.
Anticancer screening reveals that compound (7c) was active
against HeLa cell line with an IC50 of 43.1 lM and compound
(7d) was found to be interesting candidate with an IC50 of 26.0
and 30.2 lM against Colo-205 and Hep G2 cell lines.
4. Experimental
4.1. General
All chemical reagents were obtained from Sigma Aldrich and
were used without further puriﬁcation. Melting points were
determined in open capillaries and are uncorrected. Infrared
(IR) spectra were recorded using FT-IR Bruker Alpha spec-
trometer, ESI-Mass spectra were recorded on Finnigan Matt
Mass spectrometer and NMR (1H and 13C) spectra were
recorded with a Bruker Ascend-400 and 200 MHz and
Bruker Ascend-400 and Jeol JNM EX-90 spectrometer.
4.2. General procedure for preparation of indole-3-carboxylates
(2a–c)
The indole-3-carboxylic acids (1a–c) (10 mmol) were esteriﬁed
in a classical manner with methanol and 4 N HCl under reﬂux
for 2–3 h. After completion, the reaction mixture was cooled
and methanol was evaporated under reduced pressure. Then
the residue was poured onto crushed ice and treated with
10% aq. NaHCO3 solution dropwise till the reaction mixture
became slightly basic in nature. The mixture was extracted
with EtOAc and the organic layer was dried over anhydrous
Na2SO4 and ﬁltered and the solvent was evaporated under
reduced pressure to get crude indole-3-carboxylates (2a–c).
Recrystallization of the crude products was carried in ethanol.d cytotoxic investigations of novel bis(indole) analogues besides antimicrobial
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6 P. Choppara et al.4.2.1. Methyl 2-(1H-indol-3-yl)acetate (2a)
Yield: 92%., Brown viscous liquid., 1H NMR (CDCl3,
400 MHz): d 3.75 (s, 3H), 3.84 (s, 2H), 7.08 (s, 1H), 7.10 (t,
J= 7.2 Hz, 1H), 7.18 (t, J= 7.6 Hz, 1H), 7.33 (d,
J= 8.0 Hz, 1H), 7.59 (d, J= 7.6 Hz, 1H), 8.22 (s, 1H)., 13C
NMR (CDCl3, 22.4 MHz): d 31.0, 51.9, 108.1, 111.1, 118.6,
119.5, 122.0, 123.2, 127.1, 136.1, 172.6. ESI-MS: m/z 212.06
[M+Na]+, IR (KBr, cm1): 1221, 1732, 3335., Anal. Calcd.
for C11H11NO2: C, 69.83, H, 5.86, N, 7.40%, Found: C,
69.82, H, 5.90, N, 7.39%.
4.2.2. Methyl 3-(1H-indol-3-yl)propanoate (2b)
Yield: 90%, Pale yellow solid, Mp: 50 C, 1H NMR (CDCl3,
400 MHz): d 2.42 (t, J= 7.6 Hz, 2H), 3.89 (t, J= 7.6 Hz,
2H), 3.69 (s, 3H), 7.01 (s, 1H), 7.14 (t, J= 7.2 Hz, 1H), 7.21
(t, J= 7.6 Hz, 1H), 7.27 (d, J= 8 Hz, 1H), 7.65 (d,
J= 8 Hz, 1H), 7.99 (s, 1H). 13C NMR (CDCl3, 22.4 MHz):
d 20.1, 34.3, 50.9, 111.0, 113.2, 117.8, 118.1, 121.4, 121.5,
126.6, 136.1, 173.0. ESI-MS: m/z 204 [M+H]+. IR (KBr,
cm1): 1240, 1724, 3329. Anal. Calcd. for C12H13NO2: C,
70.92, H, 6.45, N, 6.89%, Found: C, 70.90, H, 6.47, N, 6.86%.
4.2.3. Methyl 4-(1H-indol-3-yl)butanoate (2c)
Yield: 93%., Pale cream ﬂuffy ﬂakes, Mp: 68 C. 1H NMR
(CDCl3, 400 MHz): d 2.01–2.08 (m, 2H), 2.39 (t, J= 7.6 Hz,
2H), 2.80 (t, J= 7.6 Hz, 2H), 3.65 (s, 3H), 6.98 (s, 1H), 7.10
(t, J= 7.2 Hz, 1H), 7.18 (t, J= 7.6 Hz, 1H), 7.33 (d,
J= 8.0 Hz, 1H), 7.59 (d, J= 7.6 Hz, 1H), 7.94 (s, 1H)., 13C
NMR (CDCl3, 22.4 MHz): d 24.4, 25.2, 33.6, 51.4, 111.0,
115.4, 118.7, 119.1, 121.4, 121.8, 127.3, 136.3, 174.1., ESI-
MS: m/z 240.09 [M+Na]+., IR (KBr, cm1): 1248, 1714,
3336., Anal. Calcd. for C13H15NO2: C, 71.87, H, 6.96, N,
6.45%, Found: C, 71.86, H, 6.99, N, 6.44%.
4.3. General procedure for preparation of indole-3-carboxylic
acid hydrazides (3a–c): (Rapolu et al., 2013)
4.4. General procedure for the synthesis of 5-substituted 1H-
indole-3-carbaldehyde (5a,b): (James and Snyder, 1959;
Choppara et al., 2015)
To a solution of substituted indoles (4a,b) (42.6 mmol) in
dry DMF (187.4 mmol) in an ice-salt bath, POCl3
(47.1 mmol) is subsequently added with stirring over a
period of 30 min. After completion of addition, raise the
temperature to 40 C and stir the syrup for 1.5 h at that
temperature. At the end of the reaction (as indicated by
TLC) 25 g crushed ice was added to the reaction mixture.
The obtained solution is transferred into 250 mL RB
ﬂask and added with NaOH (470 mmol) dissolved in
50 mL water with constant stirring and the resultant
suspension is heated rapidly to the boiling point and allowed
to cool to room temperature, after which it is placed in
refrigerator overnight. The precipitate was ﬁltered off and
washed thrice with 100 mL water, yielding 5-substituted
1H-indole-3-carbaldehyde (5a,b).
4.4.1. 1H-indole-3-carbaldehyde (5a): (James and Snyder,
1959; Choppara et al., 2015)
Yield: 92%., Brownish yellow solid., Mp: 196–198 C., 1H
NMR (DMSO-d6, 400 MHz): d 7.14 (t, J= 7.2 Hz, 1H),Please cite this article in press as: Choppara, P. et al., Synthesis, characterization a
study. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.20157.22 (t, J= 7.2 Hz, 1H), 7.34 (d, J= 8 Hz, 1H), 7.52 (s,
1H), 7.62 (d, J= 8 Hz, 1H), 8.12 (s, 1H), 9.52 (s, 1H). 13C
NMR (DMSO-d6, 22.4 MHz): d 111.4, 118.0, 119.4, 120.5,
122.4, 127.7, 131.82, 137.2, 182.7. ESI-MS: m/z 146.20
[M+H]+. IR (KBr, cm1): 1229, 1632, 3442. Anal. Calcd.
for C9H7NO: C, 74.47, H, 4.86, N, 9.65%, Found: C, 74.44,
H, 4.91, N, 9.64%.
4.4.2. 5-bromo-1H-indole-3-carbaldehyde (5b): (Choppara
et al., 2015)
Yield: 90%., Cream coloured solid., Mp: 192 C. 1H NMR
(DMSO-d6, 400 MHz): d 7.34 (d, J= 8.8 Hz, 1H), 7.43 (d,
J= 8.4 Hz, 1H), 7.75 (s, 1H), 8.25 (s, 1H), 8.32 (s, 1H), 9.94
(s, 1H). 13C NMR (DMSO-d6, 22.4 MHz): d 113.0, 114.8,
117.3, 123.1, 125.6, 135.2, 136.7, 144.4, 183.9. ESI-MS: m/z
245.95 [M+Na]+. IR (KBr, cm1): 1229, 1643, 3312. Anal.
Calcd. for C9H6BrNO: C, 48.25, H, 2.70, N, 6.25%, Found:
C, 48.22, H, 2.76, N, 6.24%.
4.5. General procedure for the synthesis of substituted 1-(3-
methylbut-2-enyl)- 1H-indole-3-carbaldehyde (6a,b)
To a solution of substituted 1H-indole-3-carbaldehydes (5a,b)
(2.20 mmol) in dry DMF (5 mL) was added NaH (2.64 mmol,
60% oil dispersion) and the resulting mixture was stirred for
10 min in an ice bath. 3,3-dimethylallyl bromide (2.20 mmol)
was added and the resulting mixture stirred for 15 min at
0 C. The mixture was diluted with EtOAc (20 mL) and
washed ﬁve times with distilled water (50 mL). The organic
layer was dried over anhydrous Na2SO4 and ﬁltered and the
solvent was removed under reduced pressure to get crude resi-
due which was puriﬁed by column chromatography (silica gel
100–200 mesh) using 8:2 (Hexane: EtOAc) as eluents affording
6a,b.4.5.1. 1-(3-methylbut-2-enyl)-1H-indole-3-carbaldehyde (6a)
Yield: 87%., Brownish yellow crystals., Mp: 79–81 C., 1H
NMR (CDCl3, 400 MHz): d 1.85 (s, 3H), 1.86 (s, 3H), 4.74
(d, J= 7.2 Hz, 2H), 5.44 (t, J= 7.2 Hz, 1H), 7.28–7.41 (m,
4H) 7.76 (s, 1H), 9.99 (s, 1H)., 13C NMR (CDCl3,
22.4 MHz): d 17.9, 25.4, 44.6, 110.0, 117.7, 117.9, 121.8,
122.7, 123.6, 125.5, 137.3, 137.5, 138.7, 184.3., ESI-MS: m/z
214.20 [M+H]+., IR (KBr, cm1): 1224, 1640., Anal. Calcd.
for C14H15NO: C, 78.84, H, 7.09, N, 6.57%, Found: C,
78.80, H, 7.16, N, 6.55%.
4.5.2. 5-bromo-1-(3-methylbut-2-enyl)-1H-indole-3-
carbaldehyde (6b)
Yield: 89%., Pale pink solid., Mp: 95–98 C., 1H NMR
(CDCl3, 400 MHz): d 1.85 (s, 3H), 1.86 (s, 3H), 4.71
(d, J= 7.2 Hz, 2H), 5.42 (t, J= 7.2 Hz, 1H), 7.25
(d, J= 9.6 Hz, 1H), 7.43 (dd, J= 2.0, 8.8 Hz, 1H),
7.73 (s, 1H), 8.47 (d, J= 2.0 Hz, 1H), 9.96 (s, 1H).,
13C NMR (CDCl3, 22.4 MHz): d 12.7, 20.1, 39.4, 106.0,
110.8, 111.7, 119.0, 121.1, 121.4, 130.3, 132.6, 132.8,
133.8, 178.6., ESI-MS: m/z 314.01 [M+Na]+., IR (KBr,
cm1): 1162, 1654., Anal. Calcd. for C14H14BrNO: C,
57.55, H, 4.83, N, 4.79%, Found: C, 57.53, H, 4.90,
N, 4.77%.nd cytotoxic investigations of novel bis(indole) analogues besides antimicrobial
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1H-indol-3-yl)methylene)-n-(1H-indol-3-yl)alkanehydrazides
(7a–f)
A mixture of indole-3-carboxylic acid hydrazides (3) (1 mmol)
and 5-substituted-1H-indole-3-carbaldehyde (5) in ethanol and
glacial acetic acid (2 drops) was reﬂuxed for 20–30 min. As the
reaction progresses, N0-((5-substituted-1H-indol-3-yl)methylene)-
n-(1H-indol-3-yl)alkanehydrazides (7a–f) separate out as a solid
in the reaction mixture. After completion of the reaction, the solid
product was collected by simple ﬁltration. Then the solid was
dried and puriﬁed by column chromatography (silica gel 100–
200 mesh) using 6:4 (Hexane: EtOAc) as eluents affording pure
compounds (7a–f).
4.6.1. N0-((1H-indol-3-yl)methylene)-2-(1H-indol-3-
yl)acetohydrazide (7a)
Yield: 87%., Brown solid., Mp: 152 C., 1H NMR (DMSO-d6,
400 MHz): d 2.87 (s, 2H), 7.02–7.83 (m, 10), 8.12 (s, 1H), 8.52
(s, 1H), 10.21 (s, 1H), 10.89 (s, 1H)., 13C NMR (DMSO-d6,
22.4 MHz): d 30.1, 108.1, 111.5, 114.3, 116.6, 116.9, 118.6,
119.7, 122.3, 123.1, 123.5, 127.5, 132.2, 132.5, 136.5, 137.5,
137.9, 140.6, 173.1. ESI-MS: m/z 317 [M+H]+., IR (KBr,
cm1): 1222, 1608, 1649, 3354, 3397, 3541., Anal. Calcd. for
C19H16N4O: C, 72.13, H, 5.10, N, 17.71%, Found: C, 72.11,
H, 5.14, N, 17.69%.
4.6.2. N0-((1H-indol-3-yl)methylene)-3-(1H-indol-3-
yl)propanehydrazide (7b)
Yield: 84%., Pale yellow solid., Mp: 300 C., 1H NMR
(DMSO-d6, 200 MHz): d 2.64 (t, J= 7.6 Hz, 2H), 2.87 (t,
J= 7.6 Hz, 2H), 6.98–7.62 (m, 10H), 8.07 (s, 1H), 8.90 (s,
1H), 10.12 (s, 1H), 10.31 (s, 1H)., 13C NMR (DMSO-d6,
22.4 MHz): d 26.3, 39.5, 111.7, 113.2, 116.8, 118.1, 119.0,
119.5, 120.2, 122.4, 123.2, 123.8, 126.1, 127.8, 128.7, 131.8,
136.0, 137.2, 140.1, 178.5., ESI-MS: m/z 331 [M+H]+., IR
(KBr, cm1): 1241, 1610, 1650, 3392, 3410, 3572., Anal.
Calcd. for C20H18N4O: C, 72.71, H, 5.49, N, 16.96%,
Found: C, 72.70, H, 5.51, N, 16.95%.
4.6.3. N0-((1H-indol-3-yl)methylene)-4-(1H-indol-3-
yl)butanehydrazide (7c)
Yield: 92%., Yellow solid., Mp: 178 C., 1H NMR (DMSO-d6,
200 MHz): d 2.01–2.08 (m, 2H), 2.25 (t, J= 7.6 Hz, 2H), 2.80
(t, J= 7.6 Hz, 2H), 6.93–7.73 (m, 10H), 8.12 (s, 1H), 8.28 (s,
1H), 10.76 (s, 1H), 10.87 (s, 1H)., 13C NMR (DMSO-d6,
22.4 MHz): d 25.4, 26.3, 32.9, 108.3, 110.6, 115.9, 117.1,
118.0, 118.7, 119.6, 120.5, 121.2, 121.8, 122.3, 124.0, 125.7,
136.2, 137.8, 138.9, 140.3, 174.2., ESI-MS: m/z 367.15
[M+Na]+., IR (KBr, cm1): 1244, 1623, 1646, 3329, 3396,
3542., Anal. Calcd. for C21H20N4O: C, 73.23, H, 5.85, N,
16.27%, Found: C, 73.20, H, 5.87, N, 16.26%.
4.6.4. N0-((5-bromo-1H-indol-3-yl)methylene)-2-(1H-indol-3-
yl)acetohydrazide (7d)
Yield: 91%., Yellow solid., Mp: 156 C., 1H NMR (DMSO-d6,
400 MHz): d 2.74 (s, 2H), 7.19–7.71 (m, 9H), 8.19 (s, 1H), 8.41
(s, 1H), 9.92 (s, 1H), 10.14 (s, 1H)., 13C NMR (DMSO-d6,
100 MHz): d 29.7, 108.0, 110.9, 114.7, 116.9, 117.3, 118.9,
119.7, 122.4, 123.4, 123.9, 126.1, 132.1, 133.2, 136.8, 137.4,Please cite this article in press as: Choppara, P. et al., Synthesis, characterization an
study. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015138.0, 149.7, 174.3., ESI-MS: m/z 395 [M]+, 397 [M+2]+.,
IR (KBr, cm1): 1229, 1621, 1657, 3382, 3410, 3527., Anal.
Calcd. for C19H15BrN4O: C, 57.74, H, 3.83, N, 14.17%,
Found: C, 57.72, H, 3.84, N, 14.15%.
4.6.5. N0-((5-bromo-1H-indol-3-yl)methylene)-3-(1H-indol-3-
yl)propanehydrazide (7e)
Yield: 89%., Pale pink solid., Mp: 186 C., 1H NMR (DMSO-
d6, 400 MHz): d 2.55 (t, J= 7.2 Hz, 2H), 3.01 (t, J= 8.0 Hz,
2H), 6.94–7.80 (m, 9H), 8.14 (s, 1H), 8.37 (s, 1H), 10.80 (s,
1H), 11.01 (s, 1H)., 13C NMR (DMSO-d6, 100 MHz): d 21.3,
35.5, 111.7, 113.4, 114.3, 114.4, 118.6, 118.8, 122.4, 122.7,
124.5, 125.4, 126.4, 127.5, 131.6, 136.2, 136.7, 139.8, 143.0,
173.6. ESI-MS: m/z 409 [M]+, 411 [M+2]+., IR (KBr,
cm1): 1251, 1616, 1654, 3293, 3423, 3540., Anal. Calcd. for
C20H17BrN4O: C, 58.69, H, 4.19, N, 13.69%, Found: C,
58.70, H, 4.17, N, 13.72%.
4.6.6. N0-((5-bromo-1H-indol-3-yl)methylene)-4-(1H-indol-3-
yl)butanehydrazide (7f)
Yield: 90%., Greenish yellow solid., Mp: 218 C., 1H NMR
(DMSO-d6, 400 MHz): d 2.06–2.13 (m, 2H), 2.17 (t,
J= 7.6 Hz, 2H), 2.75 (t, J= 7.6 Hz, 2H), 6.89–7.82 (m,
9H), 8.28 (s, 1H), 8.36 (s, 1H), 10.54 (s, 1H), 10.91 (s, 1H).,
13C NMR (DMSO-d6, 100 MHz): d 24.8, 27.1, 33.1, 108.6,
111.2, 115.8, 117.4, 118.1, 118.5, 119.2, 120.9, 121.1, 122.3,
122.9, 123.6, 125.5, 136.7, 137.3, 138.7, 140.1, 173.2., ESI-
MS: m/z 437 [M+], 439 [M+2]+., IR (KBr, cm1): 1250,
1631, 1657, 3381, 3408, 3496., Anal. Calcd. for
C21H19BrN4O: C, 59.58, H, 4.52, N, 13.24%, Found: C,
59.60, H, 4.49, N, 13.25%.
4.7. General procedure for preparation of N0-((5-substituted-1-
(3-methylbut-2-enyl)-1H-indol-3-yl)methylene)-n-(1H-indol-3-
yl)acetohydrazide (8a–f)
A mixture of indole-3-carboxylic acid hydrazides (3) (1 mmol)
and 5-substituted-1-(3-methylbut-2-enyl)-1H-indole-3-
carbaldehyde (6) (1 mmol) in ethanol and glacial acetic acid
was reﬂuxed for 20–45 min. As the reaction progresses, N0-((
5-substituted-1-(3-methylbut-2-enyl)-1H-indol-3-yl) methylene)-
n-(1H-indol-3-yl) acetohydrazide (8a–f) separates out as a
solid in the reaction mixture. After completion of the reaction,
the solid product was collected by simple ﬁltration. The
product was puriﬁed by column chromatography (silica gel
100–200 mesh) using 6:4 (Hexane: EtOAc) as eluents affording
pure products (8a–f).
4.7.1. 2-(1H-indol-3-yl)-N0-((1-(3-methylbut-2-enyl)-1H-
indol-3-yl)methylene)acetohydrazide (8a)
Yield: 95%., Yellow solid., Mp: 180 C. 1H NMR (DMSO-d6,
200 MHz): d 1.58 (s, 3H), 1.79 (s, 3H), 3.32 (s, 2H), 4.52 (d,
J= 7.2 Hz, 2H), 5.31 (t, J= 7.2 Hz, 1H), 6.96–8.14 (m,
10H), 8.34 (s, 1H), 8.97 (s, 1H), 10.21 (s, 1H)., 13C NMR
(DMSO-d6, 22.4 MHz): d 17.9, 25.8, 31.3, 45.8, 108.5, 111.4,
111.6, 113.0, 116.2, 118.6, 118.8, 119.9, 120.8, 121.1, 122.1,
122.9, 124.7, 124.9, 127.8, 132.3, 132.1, 136.1, 140.5, 174.4.,
ESI-MS: m/z 385 [M+H]+., IR (KBr, cm1): 1224, 1615,
1651, 3272, 3452., Anal. Calcd. for C24H24N4O: C, 74.97, H,
6.29, N, 14.57%, Found: C, 74.94, H, 6.33, N, 14.55%.d cytotoxic investigations of novel bis(indole) analogues besides antimicrobial
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indol-3-yl)methylene) propane hydrazide (8b)
Yield: 87%., Cream coloured solid., Mp: 184 C., 1H NMR
(DMSO-d6, 200 MHz): d 1.82 (s, 3H), 1.85 (s, 3H), 2.31 (t,
J= 7.6 Hz, 2H), 2.82 (t, J= 7.6 Hz, 2H), 4.71 (d,
J= 7.2 Hz, 2H), 5.39 (t, J= 7.2 Hz, 1H), 6.92–7.83 (m,
10H), 8.09 (s, 1H), 8.80 (s, 1H), 10.50 (s, 1H)., 13C NMR
(DMSO-d6, 22.4 MHz): d 17.5, 24.7, 26.1, 37.8, 45.4, 110.2,
111.0, 115.2, 117.4, 118.0, 118.9, 119.5, 120.5, 121.8, 122.1,
122.6, 124.1, 125.7, 127.4, 136.7, 137.2, 137.6, 139.0, 140.1,
175.7. ESI-MS: m/z 399 [M+H]+., IR (KBr, cm1): 1071,
1620, 1671, 3321, 3467., Anal. Calcd. for C25H26N4O: C,
75.35, H, 6.58, N, 14.06%, Found: C, 75.33, H, 6.60, N,
14.05%.
4.7.3. 4-(1H-indol-3-yl)-N0-((1-(3-methylbut-2-enyl)-1H-
indol-3-yl)methylene)butane hydrazide (8c)
Yield: 87%., Cream coloured solid., Mp: 172–174 C. 1H
NMR (DMSO-d6, 200 MHz): d 1.79 (s, 3H), 1.81 (s, 3H),
2.04–2.10 (m, 2H), 2.27 (t, J= 7.6 Hz, 2H), 2.76 (t,
J= 7.6 Hz, 2H), 4.63 (d, J= 7.2 Hz, 2H), 5.39 (t,
J= 7.2 Hz, 1H), 6.97–7.85 (m, 10H), 8.20 (s, 1H), 8.36
(s, 1H), 10.81 (s, 1H)., 13C NMR (DMSO-d6, 22.4 MHz):
d 17.9, 24.6, 25.7, 26.1, 33.8, 45.1, 110.1, 110.8, 115.5,
117.6, 117.9, 118.7, 119.2, 120.7, 121.7, 121.9, 122.4,
123.7, 125.3, 127.2, 136.6, 137.2, 137.4, 138.9, 140.1,
175.1., ESI-MS: m/z 451.18 [M+K]+., IR (KBr, cm1):
1231, 1624, 1669, 3331, 3472., Anal. Calcd. for
C26H28N4O: C, 75.70, H, 6.84, N, 13.58%, Found: C,
75.69, H, 6.85, N, 13.57%.4.7.4. N0-((5-bromo-1-(3-methylbut-2-enyl)-1H-indol-3-
yl)methylene)-2-(1H-indol-3-yl)acetohydrazide (8d)
Yield: 89%., White solid., Mp: 178 C., 1H NMR (DMSO-d6,
400 MHz): d 1.52 (s, 3H), 1.71 (s, 3H), 3.29 (s, 2H), 4.52 (d,
J= 7.2 Hz, 2H), 5.28 (t, J= 7.2 Hz, 1H), 7.02–8.17 (m,
9H), 8.41 (s, 1H), 8.99 (s, 1H), 10.35 (s, 1H)., 13C NMR
(DMSO-d6, 100 MHz): d 16.3, 24.2, 31.6, 44.9, 108.1, 111.2,
111.7, 113.2, 116.6, 118.7, 119.2, 119.5, 120.8, 121.3, 122.5,
123.6, 124.8, 125.8, 127.6, 132.6, 132.2, 135.0, 140.7, 173.2.,
ESI-MS: m/z 463 [M]+, 465 [M+2]+., IR (KBr, cm1):
1212, 1624, 1658, 3325, 3487., Anal. Calcd. for
C24H23BrN4O: C, 62.21, H, 5.00, N, 12.09%, Found: C,
62.20, H, 5.02, N, 12.06%.4.7.5. N0-((5-bromo-1-(3-methylbut-2-enyl)-1H-indol-3-
yl)methylene)-3-(1H-indol-3-yl)propanehydrazide (8e)
Yield: 94%., Cream coloured solid., Mp: 194 C., 1H NMR
(DMSO-d6, 200 MHz): d 1.57 (s, 3H), 1.76 (s, 3H), 2.34 (t,
J= 7.2 Hz, 2H), 2.80 (t, J= 7.2 Hz, 2H), 4.67 (d,
J= 7.2 Hz, 2H), 5.43 (t, J= 7.2 Hz, 1H), 6.99–7.91 (m,
9H), 8.27 (s, 1H), 8.71 (s, 1H), 10.42 (s, 1H)., 13C NMR
(DMSO-d6, 50 MHz): d 16.9, 24.4, 27.1, 37.4, 45.9, 110.3,
111.5, 115.1, 117.9, 118.3, 119.3, 119.8, 120.3, 121.7, 122.3,
122.8, 124.8, 125.6, 127.2, 136.3, 137.1, 137.8, 139.3, 140.3,
176.2., ESI-MS: m/z 477 [M]+, 479 [M+2]+., IR (KBr,
cm1): 1190, 1628, 1671, 3401, 3563., Anal. Calcd. for
C25H25BrN4O: C, 62.90, H, 5.28, N, 11.74%, Found: C,
62.88, H, 5.29, N, 11.73%.Please cite this article in press as: Choppara, P. et al., Synthesis, characterization a
study. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.20154.7.6. N0-((5-bromo-1-(3-methylbut-2-enyl)-1H-indol-3-
yl)methylene)-4-(1H-indol-3-yl)butanehydrazide (8f)
Yield: 90%., White solid., Mp: 182 C., 1H NMR (DMSO-d6,
400 MHz): d 1.65 (s, 3H), 1.74 (s, 3H), 2.02–2.11 (m, 2H), 2.26
(t, J= 7.2 Hz, 2H), 2.81 (t, J= 7.2 Hz, 2H), 4.51 (d,
J= 7.6 Hz, 2H), 5.31 (t, J= 7.6 Hz, 1H), 7.12–7.85 (m,
9H), 8.13 (s, 1H), 8.28 (s, 1H), 10.72 (s, 1H)., 13C NMR
(DMSO-d6, 100 MHz): d 16.8, 25.2, 25.9, 27.4, 33.9, 45.3,
110.9, 111.4, 116.2, 117.7, 118.1, 118.8, 119.5, 120.8, 121.9,
122.4, 122.9, 123.8, 125.2, 127.9, 136.9, 137.5, 137.9, 138.7,
140.5, 174.7., ESI-MS: m/z 514 [M+Na]+, 512
[M+Na+2]+., IR (KBr, cm1): 1239, 1619, 1674, 3291,
3463., Anal. Calcd. for C26H27BrN4O: C, 63.55, H, 5.54, N,
11.40%, Found: C, 63.57, H, 5.57, N, 11.39%.
4.8. Antibacterial assay
100 mL sterile conical ﬂask of nutrient broth was inoculated
with the test organisms and incubated at 37 C overnight. By
using a sterile pipette, 0.6 mL of the broth culture of each test
organism was added to 60 mL of molten agar, mixed well and
maintained at 45 C. Sterile agar test plates of each test organ-
ism were prepared by pouring inoculated medium with uni-
form thickness. The agar was allowed to set and harden and
wells of 4 mm diameter were cut at equidistant using a sterile
cork borer. Agar plugs were removed. 100 lg/mL of test solu-
tions (7a–f) and (8a–f) were prepared in DMSO and were
introduced into the wells using micropipette. The plates were
kept at room temperature for 2 h for better diffusion of solu-
tion into the medium. The plates were incubated for 24 h at
37 C. After incubation the diameter of inhibitory zones
formed around each well was measured in millimetre (mm)
using antibiotic zone scale. The assay was carried out in dupli-
cate. DMSO was used as control and the antibacterial activity
of the test compounds was compared with standard
‘‘ciproﬂoxin’’.
4.9. Antifungal assay
Sterile molten potato dextrose agar (PDA) medium was inoc-
ulated with 50 lL of fungal spore suspension aseptically and
maintained at 45 C temperature. The inoculated medium
was mixed well and poured immediately in sterilized petri
plates. Then ﬁve wells of 6 mm diameter were punched using
sterile borer and ﬁlled with 100 lg/mL of test compounds
(7a–f) and (8a–f) as well as sterile DMSO 100% as negative
control. Plates were incubated for 24 h at 37 C. Antifungal
activity was determined by measuring the zone of inhibition.
The zones produced by the test compounds were compared
with the ketoconazole (standard).
4.10. Anticancer activity
4.10.1. Cell lines and cell culture
The cell lines are (Colo 205) Human colon cancer cell line, Hep
G2, hepatocellular carcinoma cell line which was derived from
the liver tissue of a 15-year-old Caucasian American male, and
HeLa (Hela or HeLa cell) the oldest and most commonly used
human cell line (Rahbari et al., 2009). The cell line was derived
from cervical cancer cells taken on February 8, 1951 (Scherernd cytotoxic investigations of novel bis(indole) analogues besides antimicrobial
.05.015
Synthesis, characterization and cytotoxic investigation of bis(indole) analogues 9et al., 1953) from Henrietta Lacks, a patient who eventually
died of cancer on October 4, 1951. George Gey was able to iso-
late one speciﬁc cell, multiply it, and start a cell line. Gey
named the sample HeLa, after the initial letters of Henrietta
Lack’s name. Colo 205 (Human colon cancer cell line), Hep
G2 (Human liver carcinoma cell line) and HeLa (Cervical can-
cer cell line) cell lines were obtained from the National Centre
for Cellular Sciences (NCCS), Pune, India. Cells were cultured
in RPMI-1640 media, supplemented with 10% heat-
inactivated fetal bovine serum (FBS), 1 mM NaHCO3, 2 mM
-glutamine, 100 units/mL penicillin and 100 lg/mL strepto-
mycin. All cell lines were maintained in culture at 37 C in
an atmosphere of 5% CO2.
4.10.2. Test concentrations
Initially, stock solutions of each test substance were prepared
in 100% Dimethyl Sulfoxide (DMSO, Sigma Aldrich) with a
ﬁnal concentration of 8 mg/mL. Exactly 50 lL of stock was
diluted to 1 mL in culture medium to obtain experimental
stock concentration of 400 lg/mL. This solution was further
serially diluted with media to generate a dilution series of
10 lg to 200 lg/mL. Precisely, 100 lL of each test concentra-
tion was added to 100 lL of cell suspension (total assay vol-
ume of 200 lL, and efﬁcacy of the derivatives was evaluated
with three different set of experiments) and incubated for
24 h at 37 C in 5% CO2.
4.10.3. Cytotoxicity
The cytotoxicity of novel bis(indole) analogues (7a–f) and (8a–
f) was screened on human colorectal cancer (Colo-205), human
hepatocellular liver carcinoma (Hep G2), and human cervical
cancer (HeLa) cell lines using etoposide as positive control
by MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetra-
zolium bromide] assay, according to the method of
Mosmann (1983). Brieﬂy, the cells (2 · 104) were seeded in
each well containing 100 lL of medium in 96 well plates.
After overnight incubation at 37 C in 5% CO2, exactly
100 lL of different test concentrations (10 lg–200 lg/mL)
was added to the cell suspension, which is equivalent to 2–
40 lg per 200 lL of assay volume. The viability of cells was
assessed after 24 h, by adding 10 lL of MTT (5 mg/mL) per
well and incubated at 37 C for additional three hours. The
medium was discarded and the formazan blue, which formed
in the cells, was dissolved in 100 lL of DMSO. The intensity
of colour formation was measured at 570 nm in a spectropho-
tometer (Spectra MAX Plus, Molecular Devices, supported by
SOFTmax PRO-5.4). The percent inhibition of cell viability
was determined with reference to the control values (without
test compound). The data were subjected to linear regression
analysis and the regression lines were plotted for the best
straight-line ﬁt. The IC50 (inhibition of cell viability) concen-
trations were calculated using the respective regression equa-
tion and expressed in lM.
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